1. Home
  2. AMRX vs FCN Comparison

AMRX vs FCN Comparison

Compare AMRX & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$17.94

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo FTI Consulting Inc.

FCN

FTI Consulting Inc.

N/A

Current Price

$155.32

Market Cap

4.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
AMRX
FCN
Founded
2002
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.6B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
AMRX
FCN
Price
$17.94
$155.32
Analyst Decision
Strong Buy
Hold
Analyst Count
5
1
Target Price
$15.60
$165.00
AVG Volume (30 Days)
1.8M
409.2K
Earning Date
05-01-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
5.51
EPS
0.37
3.89
Revenue
N/A
$3,788,857,000.00
Revenue This Year
$4.48
$7.39
Revenue Next Year
$7.13
$7.10
P/E Ratio
$48.95
$39.53
Revenue Growth
N/A
2.44
52 Week Low
$9.20
$137.65
52 Week High
$19.26
$189.30

Technical Indicators

Market Signals
Indicator
AMRX
FCN
Relative Strength Index (RSI) 51.26 49.28
Support Level $16.61 $153.47
Resistance Level $18.13 $166.98
Average True Range (ATR) 0.67 4.41
MACD -0.09 -0.23
Stochastic Oscillator 48.32 36.99

Price Performance

Historical Comparison
AMRX
FCN

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About FCN FTI Consulting Inc.

FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.

Share on Social Networks: